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Abstract: Too few patients utilize cardiac rehabilitation (CR), despite its benefits. The Cochrane
review assessing the effectiveness of interventions to increase CR utilization (enrolment, adherence,
and completion) was updated. A search was performed through July 2018 of the Cochrane and
MEDLINE (Medical Literature Analysis and Retrieval System Online) databases, among other
sources. Randomized controlled trials in adults with myocardial infarction, angina, revascularization,
or heart failure were included. Interventions had to aim to increase utilization of comprehensive
phase II CR. Two authors independently performed all stages of citation processing. Following the
random-effects meta-analysis, meta-regression was undertaken to explore the impact of pre-specified
factors. Twenty-six trials with 5299 participants were included (35.8% women). Low-quality evidence
showed an effect of interventions in increasing enrolment (risk ratio (RR) = 1.27, 95% confidence
interval (CI) = 1.13–1.42). Meta-regression analyses suggested that the intervention deliverer (nurse
or allied healthcare provider, p = 0.02) and delivery format (face-to-face, p = 0.01) were influential
in increasing enrolment. There was low-quality evidence that interventions to increase adherence
were effective (standardized mean difference (SMD) = 0.38, 95% CI = 0.20–0.55), particularly where
remotely-offered (SMD = 0.56, 95% CI = 0.36–0.76). There was moderate-quality evidence that
interventions to increase program completion were effective (RR = 1.13, 95% CI = 1.02–1.25). There are
effective interventions to increase CR utilization, but more research is needed to establish specific,
implementable materials and protocols, particularly for completion.
Keywords: coronary artery disease; secondary prevention; healthcare access; cardiac rehabilitation
1. Introduction
The burden of cardiovascular disease (CVD) is substantial, and it is among the leading causes
of disability worldwide [1–3]. Cardiac rehabilitation (CR) is a medically-sponsored program to aid
recovery and prevent further cardiac events. It includes specific core components that aim to optimize
cardiovascular risk reduction, foster healthy behaviors, increase the patient’s understanding of their
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disease, and improve psychosocial well-being [4,5]. On average, patients attend a program 2 times a
week over 5 months [6].
CR has been shown to improve quality of life, as well as decrease subsequent morbidity and
cardiovascular mortality by approximately 20% [7]. As a result, CR is an integral recommendation in
many clinical guidelines for secondary prevention in cardiac patients [8–13]. By promoting the
utilization of CR, patients can achieve the benefits of participation. Indeed, the more patients
participate, the better the outcomes that are achieved [14]. However, CR utilization remains suboptimal.
It is estimated that only 30% of eligible patients participate [15–18]. Such under-utilization can be
attributed in part to low referral rates by healthcare providers [19]. However, even among individuals
referred to CR, few enroll in the program and many of those who do drop out [20]. Factors impacting
utilization of CR include distance, financial resources, work and other time constraints, gender, age,
social support, illness perceptions, and depression [21].
The 2014 Cochrane systematic review evaluating interventions that promote utilization of CR
identified effective interventions to increase CR enrolment [22]. However, this review did not identify
sufficient evidence to provide recommendations on interventions to increase adherence; program
completion was not considered. Meta-analyses were not undertaken, nor was the quality of evidence
rated in accordance with the Grading of Recommendations, Assessment, Development and Evaluation
(GRADE) [23]. In recent years, several new trials have been published. The purpose of this study
was to undertake an updated systematic review and meta-analysis, applying current Cochrane
methodological standards, of interventions to increase patient enrolment, adherence, and completion
of CR, as well as to consider equity, costs, and harms.
2. Methods
2.1. Search Methods for Identification of Studies
The search strategies were designed in accordance with Cochrane Heart Group methods and
guidance. A generic search strategy was initially designed, as this review forms part of a broader set
of Cochrane CR reviews [7,24,25].
The following databases were searched from 2013: (1) Cochrane Central Register of Controlled
Trials, July 2018 (Cochrane Library, Wiley, Hoboken, NJ, USA); (2) Database of Abstracts of Reviews of
Effects April 2015 (Cochrane Library, Wiley); (3) Health Technology Assessment Database, October
2016 (Cochrane Library, Wiley); (4) MEDLINE through to July 2018 (Ovid, New York, NY, USA);
(5) MEDLINE In-Process & Other Non-Indexed Citations through to July 10, 2018 (Ovid) and
MEDLINE®Epub Ahead of Print to July 10, 2018 (Ovid); (6) Embase, Embase Classic, and Medline
(Elsevier, Amsterdam, Netherlands); (7) Cumulative Index to Nursing and Allied Health Literature
(EBSCOhost); and (8) Conference Proceedings Citation Index-Science (CPCI-S) (Web of Science,
Clarivate Analytics, Philadelphia, PA, USA).
Reference lists from systematic reviews and meta-analysis (e.g., Matata et al., 2017 [26]) were
hand-searched for potentially-relevant articles. Main authors of studies and experts in this field
were asked for any missed, unreported, or ongoing trials. Other resources, including trial registers
(Clinicaltrials.gov and the World Health Organization International Clinical Trials Registry), were
searched to identify recent or ongoing trials.
2.2. Inclusion and Exclusion Criteria
Randomized or quasi-randomized controlled trials (RCTs), either at individual or cluster levels,
with either parallel groups or cross-over designs were included. Adults (ages 18 years or over)
with myocardial infarction (MI), angina, following coronary artery bypass graft (CABG) surgery,
percutaneous coronary intervention (PCI), or with heart failure (HF) who were eligible for CR were
included. For studies of enrolment, the study population comprised patients who were eligible for CR.
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For studies of interventions for increasing adherence or completion, participants were those who had
already enrolled to take part in a CR program at the start of the study.
Any interventions with the specific aim of increasing patient utilization of CR were considered.
CR programs were defined as those that were comprehensive, phase II (i.e., post-acute care) programs,
that offered: (1) Initial patient assessment, (2) prescribed, structured exercise, and (3) at least one other
strategy to control CVD risk factors. Interventions could be targeted to individuals, groups, partners,
caregivers or other family members, or healthcare professionals.
Primary outcome measures for this review included: (1) Enrolment in a CR program, defined
as patient attendance at a first visit (dichotomous, Y/N), (2) adherence to CR, defined as percentage
of total prescribed sessions completed, or (3) completion, where patients attended at least some of
the CR intervention components and had a formal re-assessment by the CR team at the conclusion of
the program (dichotomous, Y/N) [27]. Trials of adherence or completion had to offer a comparable
CR program in the usual care arm. Secondary outcomes included: (1) Harm or adverse events
related to the intervention (not CR); (2) costs (i.e., to implement the intervention, or of healthcare
avoidance as a result of the intervention), and; (3) equity (i.e., intervention aims to increase utilization
in under-represented groups).
2.3. Selection of Studies for Inclusion
References identified were imported into Covidence. Two authors (C.P. and G.C.) independently
screened titles and abstracts. The full-text reports of potentially-eligible trials were obtained and again
these two authors independently assessed them for eligibility. Any disagreements were resolved by
discussion or, where agreement could not be reached, by consultation with a third author (S.G.).
2.4. Data Extraction and Management
An updated data extraction form based on the one developed for the previous review, the
Cochrane Heart group template for RCTs, and the amendments to the protocol for this updated review
was developed. Two authors (C.P. and G.C.) independently extracted relevant data characterizing
study design, participants, intervention features, risk of bias, and results. One author each transferred
extracted data into Review Manager (G.C.) and a statistical software program (C.P.), and second author
(C.P. and S.G., respectively) spot-checked the data for accuracy.
2.5. Assessment of Potential Bias
At least two authors (C.P. and G.C.) independently assessed the risk of bias in newly-included
trials for this update using the Cochrane Collaboration’s recommended tool [28]. Because of the
nature of the interventions studied, it was not considered possible to assess the blinding of personnel
and participants to treatment assignment (nevertheless this could bias results). Thus, the blinding of
outcome assessors was instead considered. Discrepancies were resolved between raters, and ratings
were verified by a third author (P.D.).
We assessed for the presence of publication bias by looking for funnel plot asymmetry and testing
this asymmetry using Egger’s test [29]. Finally, one author (CP) used the GRADE Profiler software to
assess the overall quality of evidence for each of the 3 outcomes in the review [30]. A second author
(PD) checked the assessment.
2.6. Data Synthesis and Analysis
Dichotomous outcomes for each comparison have been expressed as risk ratios (RR) with 95%
confidence intervals (CI). The continuous outcome of adherence was expressed as standardized
mean differences. To perform the meta-analysis, RevMan 5.3 [31] was used. Results were pooled by
random-effects meta-analysis with the DerSimonian-Laird method. Heterogeneity amongst included
studies was first explored qualitatively by comparing characteristics of included trials and then
by visually inspecting forest plots. It was also assessed quantitatively by the Chi2 and I2 statistic.
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I2 values around 30–60% were considered indicative of a moderate level of statistical heterogeneity [28],
warranting further investigation through random-effects meta-regression.
The univariate meta-regression was undertaken in STATA version 15.1 [32] to explore heterogeneity
and examine potential intervention effect modifiers, as pre-specified below. Meta-regression was only
performed where at least 10 comparisons were included for an outcome [33]. Given the small number
of included trials, it was not considered possible to examine more than one subgroup simultaneously.
Given the number of tests performed and hence the potential for error, a more conservative p-value
of <0.01 was applied (with values < 0.05 considered trends).
The following subgroup analyses were conducted where possible (i.e., sufficient number of trials
in each category) to explore significant heterogeneity: (1) Intervention intensity (# of contacts; e.g.,
mail, visit, calls); (2) intervention deliverer (nurse or allied health care provider vs. other or none);
(3) delivery format (any face-to-face vs. no face-to-face); (4) theory-based intervention (yes vs. no);
(5) peer navigation (yes vs. no); (6) intervention target (patient vs other); (7) outcome ascertainment
(self vs. chart report); (8) multi-center study (multi-site vs. single center); (9) cardiac indication
(HF included vs. not included); (10) region (North America vs. other); (11) setting of CR (supervised
vs any unsupervised); (12) CR program duration (>3 months vs. <3 months); (13) intervention timing
(delivered pre-CR vs. during CR). The last 2 were only considered relevant to the outcomes of
adherence and completion.
3. Results
The study selection process is illustrated in the flow diagram in Figure 1. The previous version
of this Cochrane review [22] included 18 trials, of which 11 were considered eligible for the current
review [34–44]. Reasons for exclusion of the 7 trials are shown in Table S1. One previously-excluded
study was included in the current review [45]. The updated electronic search yielded 6430 unique
citations (Figure 1). Details regarding excluded and ongoing trials, as well as those awaiting
classification, are reported elsewhere [46]. Ultimately, 14 new trials met the inclusion criteria [47–61].
Thus, 26 trials (5299 participants) have been included in this update; the details of each trial are shown
elsewhere [46].
3.1. Included Studies by Outcome
Sixteen trials (3164 participants) evaluating interventions to increase CR enrolment were
included [36–39,41–45,47,51,55–59]. In all 16, the outcome could be quantified in a manner comparable with
the definition used herein, for the purposes of quantitative pooling. Eleven trials (2323 participants)
evaluating interventions to increase adherence to CR were included. [34,35,41,48–54,61,62] Of these
RCTs, in 8 (72.7%) the outcome was quantified in a manner comparable with the definition used herein
(exceptions were Bertelsen et al. [48], McGrady et al. [61], and Pack et al. [41]). Finally, the outcome
of completion was examined for the first time in this review. Seven RCTs (1567 participants) were
included for this outcome [34,40,41,49,51,54,59] (8 comparisons). All trials could be included in the
quantitative analysis.
Harms were not measured systematically as a pre-specified outcome for the intervention in any
study. Trials may have reported adverse events (or lack thereof) associated with CR participation.
Two RCTs included herein incorporated an economic analysis [48,53]. One trial examined the role
of home-based CR in increasing adherence, and the other assessed the cost-utility of offering CR in
primary care and in the community versus in the hospital.
Six (23.1%) trials applied strategies to increase utilization of CR in previously under-represented
patient subsets (i.e., women [35,43,51] and older people [37,45,49]), as per our equity focus.
For example, Beckie et al. [35] compared the effect of a gender-tailored CR program with
motivational interviewing versus traditional CR on attendance in exercise and education sessions,
and Grace et al. [51] compared utilization rates among women referred to supervised mixed-sex
(traditional), women-only (not necessarily gender-tailored), or home-based CR. Dolansky et al. [37]
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studied the effect of a family-directed intervention delivered post-acute care to patients discharged
to an inpatient longer-term care facility or receiving home care. Allied healthcare providers in these
settings provided cardiac self-management instruction and exercise monitoring.
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3.2. Characteristics of Included Studies
Trial, patient, CR program, and intervention characteristics in included studies are shown in
Table S2. The majority of trials had 2 arms, but one study had 3 arms [51] and one study was
a two-by-two factorial d s gn with four arms [55]. One trial was cluster-randomized by general
practice [38]. The trial investigator was contacted but could not provide the necessary information to
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adjust for clustering. This study has contributed to the numerical analysis as if it were individually
randomized. The majority (i.e., ≥50%) of participants in twenty-one (80.7%) trials were male, with
rates ranging between 66.0% and 87.2% [34,36,38–42,44,47–50,52–59,61] (Table S2). Most trials included
patients with more than one indication for CR (n = 22; 84.6%). Please note that Godoy included some
primary prevention patients in their sample [50].
3.3. Intervention Characteristics
The included trials tested a variety of strategies to increase utilization of CR (Table S2 and see
Reference [46] for more details). However, the intervention in many trials consisted of contacts by a
healthcare provider during or shortly after an acute care hospitalization. For example, several trials
utilized a structured telephone call or visit after hospital discharge [36,38,39,43]. Cossette et al. [36]
studied the effect of a nursing intervention focused on illness perceptions with a combination of
telephone and face-to-face meetings during the 10 days after hospital discharge. Price et al. [43] studied
the effects of a nurse-delivered telephone coaching program. McPaul et al. [39] studied the effects of
home visits versus telephone follow-up by an occupational therapist on CR attendance.
In 15 (57.7%) trials, the interventions were theory-based [34–37,40,43–45,49,50,53–56].
For example, Wyer et al. [44] evaluated the effects of motivational letters based on the Theory of
Planned Behavior, and others were based on the Social-Cognitive Theory [43,49,56]. Four (15.4%) trials
used peer navigation to promote utilization [42,45,47,57]. In 8 (30.8%) RCTs, the strategy to increase
utilization was to offer CR in an unsupervised setting [47,49–53,56,59] (i.e., remotely); in 4 trials,
these home-based programs exploited information and communications technology [52,53,56,59].
Overall, the interventions to increase utilization consisted of a mean of 14.5 ± 32.3 contacts. In almost
all trials (n = 23, 88.5%), the intervention was targeted at the cardiac patient; other targets were
nurses, [38] family [37], and groups of patients [49]. In 13 (50.0%) trials, the intervention was delivered
pre-CR [36–39,41–45,47,55,57,58].
3.4. Risk of Bias in Included Studies
The risk of bias in the 26 included trials given available information is summarized in Figure 2.
For 18 (69.2%) trials, the risk was low in 4 or more of the 6 domains.
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element are presented as percentages across all included trials.
Some other potential sources of bias should be considered. First, some trials applied unsupervised
programs as a means to increase utilization. These programs do not consist of typical on-site sessions.
Therefore, adherence was operationalized as for example completing exercise diaries or logging
in to an online system [59]. Thus, in these trials, the operationalization of adherence would be
different in both arms (i.e., vs. attendance at supervised sessions). Moreover, it could be argued that
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completion of online sessions versus going on-site in person for a discharge assessment are not highly
comparable. Therefore, results from the trials with unsupervised or hybrid arms [51,53,59] should be
considered closely. Second, in the CR4HER trial [51], there was a number of participants that switched
treatment groups.
3.5. Effects of Interventions
Ultimately 24 (92.30%) trials identified were appropriate for quantitative pooling based on
outcome operationalization. A summary of the findings is shown in Table 1. Table 2 shows results of
the meta-regression (for enrolment only; there was an insufficient number of comparisons for the other
outcomes) where there was a sufficient number of RCTs in each subgroup to run the analysis.
Table 1. Summary of findings.
Outcomes
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Participants
(Studies) Follow Up
Certainty of the
Evidence (GRADE)
Relative Effect
(95% CI)
Anticipated Absolute Effects * (95% CI)
Risk with No
Interventions to
Promote Utilization
of CR
Risk Difference
WITH Interventions
to Promote
Utilization of CR
Enrolment 3096 (19 RCTs) –
11 weeks ⊕⊕		LOW
1,2 RR 1.27
(1.13 to 1.42)
Study population
406 per 1000 110 more per 1000(53 more to 171 more)
Adherence 1654 (9 RCTs) –18 weeks ⊕⊕		LOW
1,2 -
SMD 0.38 SD higher
(0.20 higher to
0.55 higher)
Completion 1565 (8 RCTs) –
24 weeks ⊕⊕⊕	MODERATE
2 RR 1.13
(1.02 to 1.25)
Study population
649 per 100 84 more per 1000(13 more to 162 more)
* The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison
group and the relative effect of the intervention (and its 95% CI). CI—confidence interval; RCT—randomized
controlled trial; RR—risk ratio; SD—standard deviation; SMD—standardized mean difference; CR—cardiac
rehabilitation. GRADE Working Group grades of evidence. High certainty (4 ⊕): we are very confident that
the true effect lies close to that of the estimate of the effect. Moderate certainty (3 ⊕): we are moderately confident
in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different. Low certainty: (1 ⊕) our confidence in the effect estimate is limited: the true effect may be
substantially different from the estimate of the effect. Very low certainty (0 ⊕): we have very little confidence in
the effect estimate: the true effect is likely to be substantially different from the estimate of effect. 1 Heterogeneity
suggests evidence of inconsistency, therefore quality of evidence downgraded by one level. 2 The included studies
consisted of primarily white male participants, therefore quality of evidence downgraded by one level for indirectness.
Table 2. Meta-regression results for enrolment.
Subgroup n Odds Ratio (95% CI) p Residual I2 *
Delivery format
(any face-to-face or no face-to-face) 3096 0.73 (0.57 to 0.93) 0.01 37%
Theory-based
(yes or no) 3096 0.98 (0.75 to 1.27) 0.86 60%
Outcome ascertainment
(self-report or chart-report) 1835 0.99 (0.99 to 1.00) 0.74 53%
Number of sites
(multi-site or single-centre) 943 0.90 (0.69 to 1.17) 0.40 60%
Region
(North America or other) 3096 0.91 (0.70 to 1.17) 0.44 60%
Intervention Intensity
(<5 contacts or ≥5 contacts) 2659 0.99 (0.99 to 1.00) 0.23 66%
Peer navigation
(yes or no) 3096 0.74 (0.50 to 1.10) 0.13 55%
Intervention deliverer
(nurse or allied health care professional or no one) 3096 0.73 (0.56 to 0.94) 0.02 37%
Intervention target
(patient or other) 3096 1.49 (0.98 to 2.28) 0.06 46%
Cardiac indication
(heart failure included or not) 2196 0.83 (0.63 to 1.10) 0.19 55%
CR setting
(supervised or unsupervised) 1650 1.03 (0.84 to 1.25) 0.76 15%
* I2 statistic represents the percentage of variation across studies that is due to heterogeneity. CI—confidence
interval; CR—cardiac rehabilitation.
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3.5.1. Enrolment
Compared with the control, the effect of interventions to increase enrolment were meaningful
(RR = 1.27, 95% CI = 1.13–1.42; Figure 3). Heterogeneity was moderate.J. Clin. Med. 2019, 8, 189 9 of 20 
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deliverer, and delivery format (Table 2). Figure 4 and Figure 5 display the forest plots. As shown, 
interventions targeting healthcare providers and delivered with at least some face-to-face element 
were more effective. For the other subgroup analyses which could be performed, none were 
significant. 
Figure 3. Forest plot summarizing the effect of cardiac rehabilitation utilization interventions on
enrollment. Note: Boxes represent the risk ratio (RR) for individual trials. The boxes are proportional
to the weight of each study in the analysis and the lines represent their 95% confidence interval (CI).
The diamond represents the pooled RR, and its width represents its 95% CI. M-H: Mantel Haenszel
method. Tau2 represents the variance of the effect size across studies. Chi2 (Cochran Q test) represents
the weighted sum of squared differences between individual studies and the pooled effect across
studies. I2 statistic represents the percentage of variation across studies that is due to heterogeneity.
Z represents the test for overall effect across all studies. df: degrees of freedom.
Meta-regression analyses revealed the following factors were related to enrolment: Intervention,
deliverer, and delivery format (Table 2). Figures 4 and 5 display the forest plots. As shown,
interventions targeting healthcare providers and delivered with at least some face-to-face element were
more effective. For the other subgroup analyses which could be performed, none were significant.
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unsupervised setting (SMD = 0.56, 95% CI = 0.37–0.76; Figure 7) were more effective in increasing 
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3.5.2. Adherence
Results of meta-analysis revealed there was low quality of evidence that interventions to increase
adherence had a positive effect (standardized mean difference (SMD) = 0.38, 95% CI = 0.20–0.55;
Figure 6). Heterogeneity was moderate. There was an insufficient number of comparisons to undertake
meta-regression. Subgroup analyses through meta-analysis revealed interventions in an unsupervised
setting (SMD = 0.56, 95% CI = 0.37–0.76; Figure 7) were more effective in increasing adherence. For the
other subgroup analyses which could be performed (i.e., intervention deliverer, delivery format,
theory-based intervention, multi-center study, cardiac indication, and region), none were significant.
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3.5.3. Completion
Compared with control, the effects of interventions to increase CR completion were promising
(RR = 1.13, 95% CI = 1.02–1.25, Figure 8). Heterogeneity was moderate. Note in the forest plots that the
effect size for Varnfield et al. [59] is considerably larger than the other trials, and could be the source of
some of this heterogeneity. Close consideration of the effect of this trial is warranted.
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3.5.4. Secondary Outcomes 
In both trials reporting on costs, the approach to increase utilization was to deliver CR outside 
of a hospital setting. In one of the two trials that examined cost [53], it was suggested that home-
Figure 8. The effect of cardiac rehabilitation utilization interventions on program completion. Note:
Boxes represent the risk ratio (RR) for individual trials. The boxes are proportional to the weight of
each study in the analysis and the lines represent their 95% confidence interval (CI). The diamond
represents the pooled RR, and its width represents its 95% CI.
Subgroup analysis through meta-analysis (Figure 9) revealed the following factor was related to
greater completion: Number of sites. Single-site trials more often resulted in greater completion than
multi-site ones, suggesting there may be an issue of generalizability of the interventions tested. For the
other subgroup analyses which could be performed (i.e., intervention intensity, intervention deliverer,
delivery format, theory-based intervention, intervention target, cardiac indication, region, the setting
of CR, intervention timing, and CR program duration), none were significant.
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3.5.4. Secondary Outcomes
In both trials reporting on costs, the approach to increase utilization was to deliver CR outside of
a hospital setting. In one of the two trials that examined cost [53], it was suggested that home-based
CR may be more cost-effective than traditional supervised CR from a societal perspective. (However,
the Cochrane review in this area suggests equivalent costs of home versus supervised CR [63]). In the
other study [48], average costs to deliver CR in the hospital versus shared between primary care and
community were comparable, as were productivity losses in participants in either model. There was
suggestion that the shared care model could be cost-effective.
In terms of equity, interventions designed to improve utilization among women [35,43,51] and
older patients [37,45,49] were tested, but could not be pooled quantitatively. With regard to the
former, results suggest offering alternative models, including women-only programs alone, may not
be effective in increasing utilization [51], but tailoring existing models to meet women’s unique needs
using a motivational orientation may be [64]. For older participants, peer navigation or post-discharge
visits may improve enrolment, and group sessions promoting self-regulation skills may increase
completion. No studies compared intervention effects by sub-population.
3.6. Publication Bias
Funnel plots could not be generated for adherence and completion as there were too few studies.
The funnel plot for enrolment is shown in Figure 10. The funnel plot showed a degree of asymmetry,
but this was not supported by statistical analysis (Egger’s test, p = 0.24).
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3.7. Overall Quality of Evidence
Based on the GRADE method [30], the quality of the evidence was low to moderate for all
outcomes (Table 1). The evidence for all outcomes was downgraded due to heterogeneity across
studies and indirectness (mostly male samples).
4. Discussion
In this first quantitative pooling of randomized trials of interventions to increase CR utilization,
it is established tha s ch approaches are indeed successful, resulti g in greater enrolment, adherence,
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and completion than is observed with usual care. There was significant heterogeneity, suggesting some
strategies are more effective than others. Enrolment interventions were most successful if delivered
by nurses or other allied healthcare professionals (e.g., physiotherapists), face-to-face, whereas for
adherence, patients adhered to a greater degree to unsupervised programs. As outlined above, however,
adherence ascertainment in supervised and unsupervised settings may not be comparable, therefore
these latter findings should be interpreted with caution. Investigating differences in functional capacity
in future research may overcome this incomparability. However, CR is shown to be of equivalent
efficacy regardless of setting [65], thus if offering CR remotely improved utilization, better outcomes
could be achieved. Many programs offer alternative models, but a low proportion of patients are
treated in these settings [66]. CR programs must be supported to augment their delivery of alternative
models through staffing and reimbursement.
Harms or adverse effects of interventions to increase CR utilization were not considered.
An observational study has suggested that offering too much reassurance and optimism to patients
about their recovery during CR discussions at the bedside may be associated with less enrolment [67].
While none of the interventions tested in the included studies were associated with significantly
lower utilization, clearly the content of structured communications during interventions should be
considered, standardized, and tested.
Healthcare providers need to be aware of the importance of their CR recommendations and
provide tangible, simple, and effective strategies to make such recommendations. Indeed, an online
course to educate inpatient cardiac care providers on how to discuss CR with patients at the bedside
has been developed to promote the implementation of the findings of this review; it is currently being
evaluated. Tools and resources from included trials have been collated at [68] http://sgrace.info.yorku.
ca/; the Centers for Disease Control Million Hearts Initiative have also collated practical tools [69].
Pooling of these diverse interventions is not informative for practice if there is no commonality,
understood mechanism, or specific protocol/materials. As there is a good rationale for increasing
utilization of CR [7,70], further high-quality research is needed to understand how the interventions
work and to ensure they are replicable. The evaluation of single strategies will make it easier to identify
the ‘active ingredients’ of interventions. Moreover, there have been other interventions tested in
non-randomized studies which warrant testing in RCTs, including systematic referral for augmenting
enrolment [51,70], among other quality improvement approaches [41].
No trial considered the cost of delivering a utilization intervention specifically. Given the nature
of some of the interventions (e.g., healthcare providers making post-discharge home visits), these
costs could be considerable and should be quantified in future trials. These costs would substantially
impact implementation in the real world. Some tested interventions, however, could be particularly
low-cost (e.g., the motivational letter by Wyer 2001 et al. [44]), and hence could be scaled-up across the
cardiac population. The costs of intervention delivery should be weighed in relation to the cost-savings
associated with CR participation.
Despite the fact that some included studies considered women and older patients specifically,
the majority of participants in the studies included in this review were middle-aged, male, acute
coronary syndrome (+/- revascularization) patients. More studies in this review update included HF
patients. This is encouraging considering HF is now a recognized indication for CR [24], yet such
patients may avoid exercise due to fear of placing excessive strain on the heart or functional limitations.
The identification of effective techniques to increase CR utilization in people with HF may, therefore,
be particularly valuable.
Intervention effectiveness in under-represented groups such as ethnic minorities, those of low
socioeconomic status, and people with comorbidities needs to be tested. Studies did not report
intervention effect by these characteristics, and given recommendations for sex and gender-based
analyses in particular [71], this should be reported in all future trials. Further trials of gender-tailored
CR are needed so that there is sufficient power to test whether they increase utilization or not. Other
strategies to increase use in women have been recently reviewed and should perhaps be the subject of
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an RCT [72]. Despite the many strengths of this review, including the application of GRADE and the
fact that this is the first time evidence has been pooled quantitatively, it suffers from some limitations
as well. As outlined above, no trials in this area can be double-blinded, and there was a risk of bias in
many trials. The evidence may not be applicable to the average cardiac patient. Heterogeneity was
also an issue.
In conclusion, this review shows that a number of different interventions can increase the
enrolment in, adherence to, and completion of CR. Interventions to enhance CR enrolment are
most effective if delivered face-to-face by healthcare providers. The resource implications of such
interventions need careful consideration. Offering unsupervised CR sessions may promote greater
adherence. More research is needed to understand specifically how to increase completion and to
establish specific, implementable intervention materials and protocols.
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